News | Clinical Decision Support | July 18, 2018

CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

May decrease use of head CT imaging in low-risk pediatric populations

CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

July 18, 2018 — A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt trauma patients who require head CT imaging, and could significantly reduce the use of CT imaging. The findings of the study are published in the July issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine (SAEM).

The lead author is Malkeet Gupta, M.D., MS, assistant clinical professor in the Department of Emergency Medicine at the University of California Los Angeles (UCLA).

The study by Gupta et al, validates the NEXUS Head Computed Tomography Decision Instrument in pediatric patients and provides clinicians with a highly sensitive tool to guide selective imaging decisions in blunt head injury patients. Unlike other decision instruments, the decision instrument asks providers to use clinical judgment to identify low-risk patients who need no imaging and then to apply the decision instrument to further reduce the planned imaging. This "judgment first, decision instrument second" approach may decrease head CT utilization in low-risk pediatric populations by up to 34 percent.

The findings of the study are discussed with Gupta in the featured episode of SGEM Hop (Skeptics Guide to EM Hot Off the Press).

Joshua S. Broder, M.D., director of the Emergency Medicine Residency Program and vice-chief for education in the Division of Emergency Medicine at Duke University School of Medicine, commented on the study, "This study provides another tool in our armamentarium for assessing pediatric patients with traumatic head injury and has the potential to reduce CT utilization. Some elements of the decision instrument are poorly predictive; scalp hematoma alone, for example, does not indicate substantial risk of injury. Changes in nomenclature could help. For example, the term 'high-risk' may not accurately describe patients who fail one or more measures on the instrument, as the rate of significant head injury in this group was approximately 7 percent. 'Non-low risk' or 'intermediate risk' may more accurately describe some patients who might be safely observed without imaging."

For more information: www.onlinelibrary.wiley.com

Reference

Gupta M., Mower W.R., Rodriguez R.M., Hendey G.W. "Validation of the Pediatric NEXUS II Head Computed Tomography Decision Instrument for Selective Imaging of Pediatric Patients with Blunt Head Trauma." Academic Emergency Medicine, April 17, 2018. https://doi.org/10.1111/acem.13431

 

Related Content

CT_Pediatric_Scan_Philips_Vereos_CT_RSNA 2016

Image courtesy of Philips Healthcare

News | Pediatric Imaging | December 10, 2019
December 10, 2019 — More than half of people who received...
Damage from concussion alters the way information is transmitted between the two halves of the brain, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Image courtesy of RSNA

News | Clinical Trials | December 10, 2019
December 10, 2019 — Damage from...
After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Texas MD Anderson Cancer Center

Image by Rudolf Langer from Pixabay 

News | Clinical Trials | December 06, 2019
December 6, 2019 — After receiving acupuncture treatment three days a week during the course of...
Timothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Research Chair in Breast Cancer Research. Photo courtesy McMaster University

Timothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Research Chair in Breast Cancer Research. Photo courtesy McMaster University. Photo courtesy of McMaster University

News | Breast Imaging | December 06, 2019
December 6, 2019 — A shorter course of higher-dose radiation treatment to part of the breast is showing promise in wo
MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier
Image by Kira Hoffmann from Pixabay  #RSNA19

Image by Kira Hoffmann from Pixabay 

News | Clinical Trials | November 30, 2019
November 30, 2019 — Researchers are trying to identify injury patterns and predict future outcomes for victims of gun
This bar graph shows breast cancer presentation by screening interval #RSNA19

This bar graph shows breast cancer presentation by screening interval. Image courtesy of study author and RSNA

News | Breast Imaging | November 28, 2019
November 28, 2019 — Cancers found in patients undergoing annual...
Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
November 28, 2019 — Reports of new cancer treatments